We are live on ! Find out more
Fidelity Investments

Fidelity Investments Portfolio holdings

AUM $1.9T
1-Year Est. Return 41.92%
 

Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.

This Fund
S&P 500
This Quarter Est. Return
+12.29%
1 Year Est. Return
+41.92%
3 Year Est. Return
+148.25%
5 Year Est. Return
+208.55%
10 Year Est. Return
+1,019.61%
AUM
$1.19T
AUM Growth
+$99.6B
Cap. Flow
-$7.58B
Cap. Flow %
-0.64%
Top 10 Hldgs %
29.73%
Holding
5,715
New
467
Increased
2,358
Reduced
2,086
Closed
337

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.64B
2
TMO icon
Thermo Fisher Scientific
TMO
+$1.16B
3
QCOM icon
Qualcomm
QCOM
+$1.02B
4
TSLA icon
Tesla
TSLA
+$911M
5
MA icon
Mastercard
MA
+$837M

Sector Composition

Rank Sector Weight
1 Technology 29.54%
2 Healthcare 13.79%
3 Consumer Discretionary 10.43%
4 Financials 10.34%
5 Communication Services 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRGA
5151
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3 ﹤0.01%
+16
New +$15
CGTX icon
5152
Cognition Therapeutics
CGTX
$96.7M
$2 ﹤0.01%
1
CHR icon
5153
Cheer Holding
CHR
$3.4M
0
ERNA icon
5154
Eterna Therapeutics
ERNA
$4.91M
0
GEG icon
5155
Great Elm Group
GEG
$69.3M
$2 ﹤0.01%
+1
New +$2
IZEA icon
5156
IZEA Worldwide
IZEA
$61.3M
$2 ﹤0.01%
+1
New +$3
IMDX
5157
Insight Molecular Diagnostics
IMDX
$156M
$2 ﹤0.01%
1
SIFY
5158
Sify Technologies
SIFY
$1.14B
0
SONN
5159
DELISTED
Sonnet BioTherapeutics
SONN
0
TACT icon
5160
Transact Technologies
TACT
$58.6M
0
TLRY icon
5161
Tilray
TLRY
$622M
0
WIMI
5162
WiMi Hologram Cloud
WIMI
$24.5M
0
BIOL
5163
DELISTED
Biolase, Inc.
BIOL
0
CORR
5164
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$2 ﹤0.01%
+2
New +$2
BITQ icon
5165
Bitwise Crypto Industry Innovators ETF
BITQ
$384M
-1
Closed -$7
CGC
5166
Canopy Growth
CGC
$410M
0
KPRX icon
5167
Kiora Pharmaceuticals
KPRX
$11.7M
0
MBRX icon
5168
Moleculin Biotech
MBRX
$2.91M
0
NDMO icon
5169
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$606M
0
DCOY
5170
Decoy Therapeutics
DCOY
$2.09M
0
VFF icon
5171
Village Farms International
VFF
$253M
$1 ﹤0.01%
+1
New +$1
THMO
5172
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$1 ﹤0.01%
1
GMBL
5173
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
0
TBLT
5174
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
0
CEI
5175
DELISTED
Camber Energy, Inc
CEI
$1 ﹤0.01%
+1
New +$1

Similar funds

Fidelity Investments's Q2 2023 Portfolio in Review

As of Q2 2023, Fidelity Investments held 5,715 positions worth $1.19T, up 9.1% from $1.09T the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Fidelity Investments's Q2 2023 filing shows 467 new, 2,358 increased, 2,086 reduced and 337 closed positions. Its largest new stake was Crane Co: 6,604,359 shares worth $589M. The largest sale was NVIDIA, an estimated $1.64B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fidelity Investments's largest Q2 2023 buy was Crane Co: 6,604,359 shares worth $589M.
  • Fidelity Investments added most to Microsoft in Q2 2023, an estimated $3B increase.
  • Fidelity Investments's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $1.64B.
  • Fidelity Investments fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $123M.
  • Fidelity Investments's ten largest holdings make up 30% of its $1.19T portfolio in Q2 2023.
  • Fidelity Investments opened 467 new positions and closed 337 in Q2 2023.
  • Fidelity Investments's portfolio value rose 9.1% quarter-over-quarter to $1.19T.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.